Publications by authors named "Benoit Mellottee"
Mucous membrane pemphigoid (MMP) is a heterogeneous group of rare, chronic, subepithelial autoimmune blistering diseases (AIBDs) with predominant involvement of mucous membranes that can be sight-threatening and life-threatening. Rituximab (RTX) has demonstrated its efficacy in severe MMP refractory to conventional immunosuppressants in small series that differed in RTX scheme, concomitant therapies, and outcome definitions. In a meta-analysis involving 112 patients with MMP treated with RTX, complete remission (CR) was reported in 70.
View Article and Find Full Text PDFArticle Synopsis
- * The study examined 313 MMP patients, identifying those who were treated with gliptins to see if there was a connection to the onset of MMP.
- * Findings showed that patients who stopped using gliptins had a higher rate of remission, while one patient who resumed treatment experienced a relapse, highlighting differences in symptoms and severity compared to MMP patients not treated with gliptins.